Wei Wu

Corporate Officer/Principal en Johnson & Johnson Innovation - JJDC, Inc. .

Consumer Services

Finance

Health Technology

Perfil

Wei Wu is currently a Principal at Johnson & Johnson Innovation - JJDC, Inc. Prior to this, he worked as a Senior Associate at IIF Management Co. LLC from 2019 to 2021.
He also served as a Board Member at Immpact Bio USA, Inc. from 2021 to 2022 and as an Advisory Board Member at Cura Therapeutics from 2019 to 2020.
Mr. Wu received his undergraduate degree from Peking University and his doctorate degree from the University of California.

Cargos activos de Wei Wu

Empresas	Cargo	Inicio
Johnson & Johnson Innovation - JJDC, Inc. Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.	Corporate Officer/Principal	01/02/2021

Todos los cargos activos de Wei Wu

Antiguos cargos conocidos de Wei Wu.

Empresas	Cargo	Fin
Immpact Bio USA, Inc. Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA.	Director/Miembro de la Junta	01/01/2022
IIF Management Co. LLC IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.	Analista de Capital Privado	01/01/2021
Cura Therapeutics Cura Therapeutics Pharmaceuticals: MajorHealth Technology Cura Therapeutics is a Canadian company that is developing innovative immunotherapies to cure cancer and infectious diseases. The company is based in QuÃƒÂ©bec, Canada. The company is developing a first-in-class multifunctional immunotherapy platform that harnesses cytokines and immune receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties. The company's lead immunotherapy, CT101, is a multifunctional cytokine fusion protein that activates and synchronizes several immune system mechanisms to destroy cancer cells. Cura Therapeutics was founded by Collin Horner, Claudia A. Penafuerte Diaz, and Claudia A. Penafuerte Diaz has been the CEO since incorporation.	Consultor / Asesor	01/01/2020

Ver el detalle de la experiencia de Wei Wu.

Formación de Wei Wu.

Peking University	Undergraduate Degree
University of California	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wei Wu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
IIF Management Co. LLC IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.	Finance
Johnson & Johnson Innovation - JJDC, Inc. Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.	Finance
Immpact Bio USA, Inc. Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA.	Health Technology
Cura Therapeutics Cura Therapeutics Pharmaceuticals: MajorHealth Technology Cura Therapeutics is a Canadian company that is developing innovative immunotherapies to cure cancer and infectious diseases. The company is based in QuÃƒÂ©bec, Canada. The company is developing a first-in-class multifunctional immunotherapy platform that harnesses cytokines and immune receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties. The company's lead immunotherapy, CT101, is a multifunctional cytokine fusion protein that activates and synchronizes several immune system mechanisms to destroy cancer cells. Cura Therapeutics was founded by Collin Horner, Claudia A. Penafuerte Diaz, and Claudia A. Penafuerte Diaz has been the CEO since incorporation.	Health Technology

Ver las conexiones de la empresa